Sort
78,016 grants matching “breast cancer”
REU Site: MedIX: Medical Informatics Experiences in Undergraduate Research
$446,384Daniela S Raicu · Depaul University · · FY2017 · CSE
MISSOURI VALLEY CANCER CONSORTIUM CCOP
$446,382Missouri Valley Cancer Consortium, Inc. · U10 · FY2001 · CA
TARGETING CRIPTO/GRP78 SIGNALING IN BREAST CANCER
$446,371Salk Institute For Biological Studies, San Diego, California, The · · FY2013 · Department of Defense
Administrative Core
$446,352Mauro Ferrari · University Of Texas Hlth Sci Ctr Houston · U54 · FY2011 · CA
Designing Magnetic Resonance Protein-based Contrast Agents with High Relaxivity
$446,352Jenny J Yang · Georgia State University · R01 · FY2012 · EB
Development and validation of clinical prediction models for the use and interpretation of multigene hereditary cancer risk assessment
$446,335Sapna Syngal · Dana-Farber Cancer Inst · R01 · FY2022 · CA
Epidemiologic Field Studies
$446,334Mitchell H Gail · Division Of Cancer Epidemiology And Genetics · ZIA · FY2012 · CA
Targeting Notch, PI3K-AKT and other novel pathways in breast cancer stem cells
$446,311Jenny C-N Chang · Methodist Hospital Research Institute · R01 · FY2011 · CA
Targeting innate immune pathways in breast cancers with chromosomal instability
$446,239Samuel F Bakhoum · Sloan-Kettering Inst Can Research · P50 · FY2022 · CA
Human Breast Cancer Stem Cell Surrogates
$446,226Wendy A Woodward · University Of Tx Md Anderson Can Ctr · R01 · FY2011 · CA
BREAST CANCER AND THE ENVIRONMENT ON LONG ISLAND
$446,211University Of North Carolina Chapel Hill · U01 · FY2001 · CA
Mechanism(s)of antitumor action of tamoxifen and soy
$446,145University Of Illinois At Chicago · R01 · FY2002 · CA
Core - Biomarker Reference Laboratory
$446,142Andrew N Hoofnagle · Fred Hutchinson Cancer Center · U2C · FY2025 · CA
DNA Analysis Facility
$446,135Benoit De Crombrugghe · University Of Tx Md Anderson Can Ctr · P30 · FY2010 · CA
(PQC6) Molecular Determinants of Quiescent Cancer Cells
$446,131Sridhar Ramaswamy · Massachusetts General Hospital · R01 · FY2014 · CA
Genetic basis of chemotherapy-induced neuropathy in a reduced complexity cross
$446,100Mohamad Imad Damaj · Virginia Commonwealth University · R01 · FY2020 · CA
USE OF MITOCHONDRIA-SPECIFIC DYE MKT-077 AS A RADIOSENSITIZER TO PREOPERATIVELY TREAT LOCALLY ADVANCED BREAST CANCER
$446,096Wayne State University · · FY2008 · Department of Defense
Non-Canonical Phosphatidylinositol Kinases in Triple Negative Breast Cancer
$446,063Brooke M Emerling · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2020 · CA
Targeting ER+ Breast Cancer Through Induced Viral Mimicry
$446,063Charles H Spruck · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2025 · CA
Non-Canonical Phosphatidylinositol Kinases in Triple Negative Breast Cancer
$446,063Brooke M Emerling · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2022 · CA
Role of the Long Non-coding RNA PVT1 in Cancer
$446,063Anindya Bagchi · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2020 · CA
Role of the Long Non-coding RNA PVT1 in Cancer
$446,063Anindya Bagchi · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2017 · CA
Understanding and Targeting the Glutamine Carrier SLC1A5 in Breast Cancer
$446,063Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2015 · CA
Non-Canonical Phosphatidylinositol Kinases in Triple Negative Breast Cancer
$446,063Brooke M Emerling · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2021 · CA
MECHANISMS OF RESISTANCE TO CHEMOTHERAPIES TARGETING BRCA-MUTANT BREAST CANCER
$445,998The Geneva Foundation · · FY2015 · Department of the Army